3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Conditions
Stomach Neoplasms
1
Pancreatic Neoplasms
1
Gastrointestinal Stromal Tumors
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Duodenal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Biliary Tract Neoplasms
1
Interventions
Oxaliplatin
2
Nivolumab
2
Leucovorin
2
Irinotecan
2
Cisplatin
2
trastuzumab deruxtecan
1
tivozanib
1
seribantumab
1
motexafin lutetium
1
entinostat
1
atezolizumab
1
apixaban
1
Thalidomide
1
Specimen Handling
1
Rivaroxaban
1
Pharmacogenomic Testing
1
Peripheral Blood Stem Cell Transplantation
1
Paclitaxel
1
Observation
1
Mesna
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Ifosfamide
1
Fluorouracil
1
Floxuridine
1
Filgrastim
1
Fentanyl
1
Etoposide
1
Erlotinib Hydrochloride
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gallbladder Neoplasms
×
apixaban
×
Sarcoma
×
Clear all
NCT03139487
2020-01-06
PRIORITY
Asan Medical Center
Phase 2
Unknown
176 enrolled